Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Neurologic Disorders Therapeutics market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Neurologic Disorders Therapeuticsmarket, defines the market attractiveness level of Neurologic Disorders Therapeutics market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Neurologic Disorders Therapeutics industry, describes the types of Neurologic Disorders Therapeutics market, the applications of major players and the market size, and deeply analyzes the current situation of the global Neurologic Disorders Therapeutics market and the development prospects and opportunities of Neurologic Disorders Therapeutics industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Neurologic Disorders Therapeutics market in Chapter 13.
By Player:
Company 1
Company 2
Company 3
Company 4
Company 5
Company 6
Company 7
Company 8
Company 9
Company 10
By Type:
Central Nervous System (CNS)
Peripheral Nervous System (PNS)
By End-User:
Paralysis
Muscle Weakness
Poor Coordination
Loss of Sensation
Seizures
Confusion
Pain and Altered Levels of Consciousness
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Neurologic Disorders Therapeutics Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Neurologic Disorders Therapeutics Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Neurologic Disorders Therapeutics Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Neurologic Disorders Therapeutics Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Neurologic Disorders Therapeutics Market Analysis and Outlook to 2022
-
7.1 Global Neurologic Disorders Therapeutics Consumption (2017-2022)
-
7.2 United States Neurologic Disorders Therapeutics Consumption (2017-2022)
-
7.3 Europe Neurologic Disorders Therapeutics Consumption (2017-2022)
-
7.4 China Neurologic Disorders Therapeutics Consumption (2017-2022)
-
7.5 Japan Neurologic Disorders Therapeutics Consumption (2017-2022)
-
7.6 India Neurologic Disorders Therapeutics Consumption (2017-2022)
-
7.7 South Korea Neurologic Disorders Therapeutics Consumption (2017-2022)
8 Region and Country-wise Neurologic Disorders Therapeutics Market Analysis and Outlook to 2028
-
8.1 Global Neurologic Disorders Therapeutics Consumption Forecast (2022-2028)
-
8.2 United States Neurologic Disorders Therapeutics Consumption Forecast (2022-2028)
-
8.3 Europe Neurologic Disorders Therapeutics Consumption Forecast (2022-2028)
-
8.4 China Neurologic Disorders Therapeutics Consumption Forecast (2022-2028)
-
8.5 Japan Neurologic Disorders Therapeutics Consumption Forecast (2022-2028)
-
8.6 India Neurologic Disorders Therapeutics Consumption Forecast (2022-2028)
-
8.7 South Korea Neurologic Disorders Therapeutics Consumption Forecast (2022-2028)
9 Global Neurologic Disorders Therapeutics Market Outlook by Types and Applications to 2022
-
9.1 Global Neurologic Disorders Therapeutics Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Central Nervous System (CNS) Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Peripheral Nervous System (PNS) Consumption and Growth Rate (2017-2022)
-
9.2 Global Neurologic Disorders Therapeutics Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Paralysis Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Muscle Weakness Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Poor Coordination Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Loss of Sensation Consumption and Growth Rate (2017-2022)
-
9.2.5 Global Seizures Consumption and Growth Rate (2017-2022)
-
9.2.6 Global Confusion Consumption and Growth Rate (2017-2022)
-
9.2.7 Global Pain and Altered Levels of Consciousness Consumption and Growth Rate (2017-2022)
10 Global Neurologic Disorders Therapeutics Market Outlook by Types and Applications to 2028
-
10.1 Global Neurologic Disorders Therapeutics Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Central Nervous System (CNS) Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Peripheral Nervous System (PNS) Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Neurologic Disorders Therapeutics Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Paralysis Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Muscle Weakness Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Poor Coordination Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Loss of Sensation Consumption Forecast and Growth Rate (2022-2028)
-
10.2.5 Global Seizures Consumption Forecast and Growth Rate (2022-2028)
-
10.2.6 Global Confusion Consumption Forecast and Growth Rate (2022-2028)
-
10.2.7 Global Pain and Altered Levels of Consciousness Consumption Forecast and Growth Rate (2022-2028)
11 Global Neurologic Disorders Therapeutics Import and Export Analysis (Top 5 Countries)
-
11.1 Global Neurologic Disorders Therapeutics Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Neurologic Disorders Therapeutics Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Neurologic Disorders Therapeutics Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Neurologic Disorders Therapeutics Market Competitive Analysis
-
14.1 Company 1
-
14.1.1 Company 1 Company Details
-
14.1.2 Company 1 Neurologic Disorders Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Company 1 Neurologic Disorders Therapeutics Product and Service
-
14.2 Company 2
-
14.2.1 Company 2 Company Details
-
14.2.2 Company 2 Neurologic Disorders Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Company 2 Neurologic Disorders Therapeutics Product and Service
-
14.3 Company 3
-
14.3.1 Company 3 Company Details
-
14.3.2 Company 3 Neurologic Disorders Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Company 3 Neurologic Disorders Therapeutics Product and Service
-
14.4 Company 4
-
14.4.1 Company 4 Company Details
-
14.4.2 Company 4 Neurologic Disorders Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Company 4 Neurologic Disorders Therapeutics Product and Service
-
14.5 Company 5
-
14.5.1 Company 5 Company Details
-
14.5.2 Company 5 Neurologic Disorders Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Company 5 Neurologic Disorders Therapeutics Product and Service
-
14.6 Company 6
-
14.6.1 Company 6 Company Details
-
14.6.2 Company 6 Neurologic Disorders Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Company 6 Neurologic Disorders Therapeutics Product and Service
-
14.7 Company 7
-
14.7.1 Company 7 Company Details
-
14.7.2 Company 7 Neurologic Disorders Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Company 7 Neurologic Disorders Therapeutics Product and Service
-
14.8 Company 8
-
14.8.1 Company 8 Company Details
-
14.8.2 Company 8 Neurologic Disorders Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Company 8 Neurologic Disorders Therapeutics Product and Service
-
14.9 Company 9
-
14.9.1 Company 9 Company Details
-
14.9.2 Company 9 Neurologic Disorders Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Company 9 Neurologic Disorders Therapeutics Product and Service
-
14.10 Company 10
-
14.10.1 Company 10 Company Details
-
14.10.2 Company 10 Neurologic Disorders Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Company 10 Neurologic Disorders Therapeutics Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Neurologic Disorders Therapeutics
-
Figure Neurologic Disorders Therapeutics Picture
-
Table Global Neurologic Disorders Therapeutics Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Neurologic Disorders Therapeutics Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Neurologic Disorders Therapeutics Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Neurologic Disorders Therapeutics Consumption by Country (2017-2022)
-
Figure United States Neurologic Disorders Therapeutics Consumption and Growth Rate (2017-2022)
-
Table Europe Neurologic Disorders Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure China Neurologic Disorders Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Japan Neurologic Disorders Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure India Neurologic Disorders Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure South Korea Neurologic Disorders Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Global Neurologic Disorders Therapeutics Consumption Forecast by Country (2022-2028)
-
Figure United States Neurologic Disorders Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Neurologic Disorders Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Neurologic Disorders Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Neurologic Disorders Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Neurologic Disorders Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Neurologic Disorders Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Central Nervous System (CNS) Consumption and Growth Rate (2017-2022)
-
Figure Global Peripheral Nervous System (PNS) Consumption and Growth Rate (2017-2022)
-
Figure Global Paralysis Consumption and Growth Rate (2017-2022)
-
Figure Global Muscle Weakness Consumption and Growth Rate (2017-2022)
-
Figure Global Poor Coordination Consumption and Growth Rate (2017-2022)
-
Figure Global Loss of Sensation Consumption and Growth Rate (2017-2022)
-
Figure Global Seizures Consumption and Growth Rate (2017-2022)
-
Figure Global Confusion Consumption and Growth Rate (2017-2022)
-
Figure Global Pain and Altered Levels of Consciousness Consumption and Growth Rate (2017-2022)
-
Figure Global Central Nervous System (CNS) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Peripheral Nervous System (PNS) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Paralysis Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Muscle Weakness Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Poor Coordination Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Loss of Sensation Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Seizures Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Confusion Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Pain and Altered Levels of Consciousness Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Neurologic Disorders Therapeutics Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Neurologic Disorders Therapeutics Export by Region (Top 5 Countries) (2017-2028)
-
Table Company 1 (Foundation Year, Company Profile and etc.)
-
Table Company 1 Neurologic Disorders Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Company 1 Neurologic Disorders Therapeutics Product and Service
-
Table Company 2 (Foundation Year, Company Profile and etc.)
-
Table Company 2 Neurologic Disorders Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Company 2 Neurologic Disorders Therapeutics Product and Service
-
Table Company 3 (Foundation Year, Company Profile and etc.)
-
Table Company 3 Neurologic Disorders Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Company 3 Neurologic Disorders Therapeutics Product and Service
-
Table Company 4 (Foundation Year, Company Profile and etc.)
-
Table Company 4 Neurologic Disorders Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Company 4 Neurologic Disorders Therapeutics Product and Service
-
Table Company 5 (Foundation Year, Company Profile and etc.)
-
Table Company 5 Neurologic Disorders Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Company 5 Neurologic Disorders Therapeutics Product and Service
-
Table Company 6 (Foundation Year, Company Profile and etc.)
-
Table Company 6 Neurologic Disorders Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Company 6 Neurologic Disorders Therapeutics Product and Service
-
Table Company 7 (Foundation Year, Company Profile and etc.)
-
Table Company 7 Neurologic Disorders Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Company 7 Neurologic Disorders Therapeutics Product and Service
-
Table Company 8 (Foundation Year, Company Profile and etc.)
-
Table Company 8 Neurologic Disorders Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Company 8 Neurologic Disorders Therapeutics Product and Service
-
Table Company 9 (Foundation Year, Company Profile and etc.)
-
Table Company 9 Neurologic Disorders Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Company 9 Neurologic Disorders Therapeutics Product and Service
-
Table Company 10 (Foundation Year, Company Profile and etc.)
-
Table Company 10 Neurologic Disorders Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Company 10 Neurologic Disorders Therapeutics Product and Service
-
